Literature DB >> 685927

Clofibrate therapy and gallstone induction.

M C Bateson, D Maclean, P E Ross, I A Bouchier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 685927     DOI: 10.1007/BF01072597

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  35 in total

1.  Letter: Effects of the normal menstrual cycle on human gallbladder bile.

Authors:  L J Bennion; R L Ginsberg; M B Garnick; P H Bennett
Journal:  N Engl J Med       Date:  1976-05-20       Impact factor: 91.245

2.  Effects of fasting on bile acid metabolism and biliary lipid composition in man.

Authors:  W C Duane; R L Ginsberg; L J Bennion
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

3.  Synthesis of cholesterol in hypercholesterolemia and its relationship to plasma trigylcerides.

Authors:  H S Sodhi; B J Kudchodkar
Journal:  Metabolism       Date:  1973-07       Impact factor: 8.694

4.  Bile-rich duodenal fluid as an indicator of biliary lipid composition and its applicability to detection of lithogenic bile.

Authors:  Z R Vlahcevic; C C Bell; P Juttijudata; L Swell
Journal:  Am J Dig Dis       Date:  1971-09

5.  The connexion between myocardial infarction and gallstones in an autopsy series.

Authors:  F Bergman; W van der Linden; J Söderström
Journal:  Acta Pathol Microbiol Scand       Date:  1968

6.  Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.

Authors:  S M Grundy
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

7.  The mechanism of increased gallstone formation in obese human subjects.

Authors:  T M Mabee; P Meyer; L DenBesten; E E Mason
Journal:  Surgery       Date:  1976-04       Impact factor: 3.982

8.  Effect of aging on biliary lipid composition and bile acid metabolism in normal Chilean women.

Authors:  V Valdivieso; R Palma; R Wünkhaus; C Antezana; C Severín; A Contreras
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

9.  Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.

Authors:  M C Bateson; P E Ross; J Murison; I A Bouchier
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

View more
  13 in total

1.  Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.

Authors:  Youcai Zhang; Andrew J Lickteig; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-22       Impact factor: 4.219

2.  Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.

Authors:  I J A M Jonkers; A H M Smelt; M Ledeboer; M E Hollum; I Biemond; F Kuipers; F Stellaard; R Boverhof; A E Meinders; C H B W Lamers; A A M Masclee
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population.

Authors:  F X Caroli-Bosc; P Le Gall; P Pugliese; B Delabre; C Caroli-Bosc; J F Demarquay; J P Delmont; P Rampal; J C Montet
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 4.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Progress in gall stone disease.

Authors:  M C Bateson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-03

6.  Gallbladder disease and hyperlipoproteinemia.

Authors:  M C Bateson
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

Review 7.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  Prevalence of gallbladder disease in hyperlipoproteinemia.

Authors:  J Ahlberg; B Angelin; K Einarsson; K Hellström; B Leijd
Journal:  Dig Dis Sci       Date:  1979-06       Impact factor: 3.199

9.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

Review 10.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.